Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Enterprise Value (2016 - 2025)

OptimizeRx's Enterprise Value history spans 16 years, with the latest figure at -$19.5 million for Q3 2025.

  • For Q3 2025, Enterprise Value fell 21.04% year-over-year to -$19.5 million; the TTM value through Sep 2025 reached -$19.5 million, down 21.04%, while the annual FY2024 figure was -$13.4 million, 3.41% up from the prior year.
  • Enterprise Value for Q3 2025 was -$19.5 million at OptimizeRx, down from -$16.6 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$13.4 million in Q4 2024 and bottomed at -$89.0 million in Q1 2022.
  • The 5-year median for Enterprise Value is -$63.5 million (2023), against an average of -$52.2 million.
  • The largest annual shift saw Enterprise Value tumbled 705.21% in 2021 before it surged 81.32% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$84.7 million in 2021, then increased by 12.45% to -$74.1 million in 2022, then soared by 81.32% to -$13.9 million in 2023, then increased by 3.41% to -$13.4 million in 2024, then tumbled by 45.88% to -$19.5 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Enterprise Value are -$19.5 million (Q3 2025), -$16.6 million (Q2 2025), and -$16.6 million (Q1 2025).